PMID- 20235153 OWN - NLM STAT- MEDLINE DCOM- 20100827 LR - 20181113 IS - 1097-4644 (Electronic) IS - 0730-2312 (Print) IS - 0730-2312 (Linking) VI - 110 IP - 2 DP - 2010 May 15 TI - Connective tissue growth factor (CTGF) transactivates nuclear factor of activated T-cells (NFAT) in cells of the osteoblastic lineage. PG - 477-83 LID - 10.1002/jcb.22561 [doi] AB - Connective tissue growth factor (CTGF), a member of the Cyr 61, CTGF, Nov (CCN) family of proteins, regulates multiple cellular functions. Overexpression of CTGF in vivo causes osteopenia, but in vitro CTGF can induce osteoblastogenesis. To investigate mechanisms involved in the effects of CTGF on osteoblastic cell differentiation, we examined whether CTGF modifies the activity of nuclear factor of activated T-cells (NFATc) 1, a transcription factor that cooperates with osterix in the formation of new bone. CTGF increased the transactivation of a transiently transfected reporter construct, where 9 NFAT binding sites direct the expression of luciferase (9xNFAT-Luc) and the activity of the Regulators of calcineurin 1 exon 4 (Rcan1.4) promoter, an NFAT target gene. We postulated that CTGF could modify the phosphorylation of NFAT by regulating glycogen synthase kinase 3beta (GSK3beta). CTGF increased the mRNA levels of Protein kinase cyclic guanosine monophosphate (cGMP) dependent type II (Prkg2), the gene encoding for cGMP dependent protein kinase II (cGKII) which phosphorylates GSK3beta. Accordingly, CTGF induced GSK3beta phosphorylation and decreased the active pool of GSK3beta, a kinase that phosphorylates NFAT and leads to its nuclear export. As a consequence, CTGF favored the nuclear localization of NFATc1. Downregulation of PRKG2 by RNA interference reversed the effect of CTGF on the transactivation of the 9xNFAT reporter construct and the Rcan 1.4 promoter, confirming the role of cGKII in the activation of NFAT by CTGF. In conclusion, CTGF enhances NFAT signaling through the induction of cGKII and the phosphorylation of GSK3beta. CI - (c) 2010 Wiley-Liss, Inc. FAU - Smerdel-Ramoya, Anna AU - Smerdel-Ramoya A AD - Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut, USA. FAU - Zanotti, Stefano AU - Zanotti S FAU - Canalis, Ernesto AU - Canalis E LA - eng GR - R01 DK045227/DK/NIDDK NIH HHS/United States GR - DK045227/DK/NIDDK NIH HHS/United States GR - R37 AR021707/AR/NIAMS NIH HHS/United States GR - R01 AR021707-30/AR/NIAMS NIH HHS/United States GR - AR021707/AR/NIAMS NIH HHS/United States GR - R01 AR021707/AR/NIAMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - J Cell Biochem JT - Journal of cellular biochemistry JID - 8205768 RN - 0 (DNA Primers) RN - 0 (NFATC Transcription Factors) RN - 0 (Nfatc1 protein, mouse) RN - 139568-91-5 (Connective Tissue Growth Factor) RN - EC 2.7.11.1 (Glycogen Synthase Kinase 3 beta) RN - EC 2.7.11.1 (Gsk3b protein, mouse) RN - EC 2.7.11.26 (Glycogen Synthase Kinase 3) SB - IM MH - Animals MH - Base Sequence MH - Blotting, Western MH - Cell Line MH - Connective Tissue Growth Factor/*physiology MH - DNA Primers MH - Glycogen Synthase Kinase 3/metabolism MH - Glycogen Synthase Kinase 3 beta MH - Mice MH - NFATC Transcription Factors/*genetics MH - Osteoblasts/*metabolism MH - RNA Interference MH - Reverse Transcriptase Polymerase Chain Reaction MH - Transcriptional Activation/*physiology PMC - PMC3008370 MID - NIHMS257410 EDAT- 2010/03/18 06:00 MHDA- 2010/08/28 06:00 PMCR- 2011/05/15 CRDT- 2010/03/18 06:00 PHST- 2010/03/18 06:00 [entrez] PHST- 2010/03/18 06:00 [pubmed] PHST- 2010/08/28 06:00 [medline] PHST- 2011/05/15 00:00 [pmc-release] AID - 10.1002/jcb.22561 [doi] PST - ppublish SO - J Cell Biochem. 2010 May 15;110(2):477-83. doi: 10.1002/jcb.22561.